Dr. Kimberly A. Brown is the chief of Gastroenterology and Hepatology at Henry Ford Hospital in Detroit. She joined the Henry Ford Medical Group in 1995 as medical director of the Liver Transplant Program and was appointed chief of the Division of Gastroenterology and Hepatology in 2003. In addition, she served as the Program Director for the GI Fellowship Program from 2003 to 2008. In 2016, she was appointed as the associate medical director for the Henry Ford Hospital Transplant Institute.

Dr. Brown received her undergraduate degree from the University of Michigan in 1981. She completed her medical degree at Wayne State University in 1985. Dr. Brown completed both her residency in internal medicine, as well as her fellowship in gastroenterology, at the University of Michigan in 1992 and was named chief medical resident in 1984-85.

Dr. Brown is a member of the American Gastroenterology Association, the American Association for the Study of Liver Disease, the American College of Gastroenterology, and the American Society of Transplantation. She served on the Board of Governors of the Henry Ford Medical Group for nine years, the Henry Ford Hospital and System Network Board, and was past co-chair of the Michigan Chapter of the American Liver Foundation. She was a founding board member for the ABIM Liver Transplantation and Advanced Hepatology Board. She is past treasurer and board member of the American Society of Transplantation and is involved with several committees for both the Society and hospital. She is a past member of the UNOS Liver and Intestines Committee and previously served on the executive board for the Liver and Intestines Community of Practice for the AST. She is past associate editor for CLDF journal. Currently, Dr. Brown is the secretary for the AASLD and serves on multiple committees in that capacity.

As chief of Gastroenterology and Hepatology and past medical director of Liver Transplantation, Dr. Brown sees and manages patients with complex liver disease both before and after liver transplantation. In conjunction with Dr. Abouljoud, she worked to develop the leading liver transplant program in the State of Michigan. As fellowship director, she managed a fellowship program of 16 GI/liver fellows and continues to be involved in structuring and monitoring their education and academic success. Dr. Brown has trained over 110 fellows in advanced hepatology and transplantation. She has published over 70 articles, 110 abstracts, and eight book chapters/reviews and is a very active clinical investigator in viral hepatitis, advanced liver disease, and post liver-transplant management.

Dr. R. Todd Frederick is a transplant hepatologist with the San Francisco Center for Liver Disease at California Pacific Medical Center. He currently serves as Clinical Director of Hepatology and Fellowship Director for Transplant Hepatology as well as the Chair of the Clinical Protocols Committee for the Division.

Dr. Frederick received his undergraduate degree in Biology from the University of California, Los Angeles and his medical degree from New York Medical College in Valhalla, New York. He completed both his Internal Medicine Residency and his Fellowship in Gastroenterology/Hepatology at the University of California, San Diego. His clinical and research interests include the management of advanced chronic liver disease and liver failure, artificial liver support systems, hepatorenal syndrome, and portal hypertension, among other topics.

Dr. Vargas is a Mayo Clinic Consultant in the Department of Gastroenterology and Hepatology and the Mayo Clinic Transplantation Center. He is the Medical Director for the Office of Clinical Research – Arizona, and a Professor of Medicine for the Mayo Clinic Alix School of Medicine in Scottsdale Arizona. Dr. Vargas is the Chair of the Clinical Research Subcommittee (CRS), and the Vice Chair of the Arizona Research Operations Management Team (ROMT).

Dr. Vargas has authored or coauthored more than 125 peer-reviewed articles in journals such as Hepatology, Gastroenterology, American Journal of Transplantation, and New England Journal of Medicine. He is a fellow of the American Association for the Study of Liver Diseases, American College of Gastroenterology, American College of Physicians, American Society of Gastrointestinal Endoscopy and American Gastroenterological Association. He was named Investigator of the Year in 2016 for Mayo Clinic Arizona , and co-chaired the AASLD/IDSA HCV group from 2016-18. In 2010, he received the Outstanding Program Director of the Year Award from the Mayo Clinic College of Medicine's Department of Education Administration.